Unknown

Dataset Information

0

Melatonin promotes neuroblastoma cell differentiation by activating hyaluronan synthase 3-induced mitophagy.


ABSTRACT: Neuroblastoma is the second most common pediatric malignancy and has a high rate of spontaneous remission. Uncovering the mechanisms underlying neuroblastoma cell differentiation is critical for therapeutic purposes. A neuroblastoma cell line (N2a) treated with either serum withdrawal (<2.5%) or melatonin (>0.1 nmol/L) for 24 hours was used as a cell differentiation research model. Interestingly, the hyaluronan synthase 3 (HAS3) protein was induced in differentiated N2a cells. N2a-allografted nude mice received an intraperitoneal injection of melatonin (40 or 80 mg/kg/day for 3 weeks). The mean tumor volume in mice treated with 80 mg/kg melatonin was smaller than that in PBS-treated mice (1416.3 and 3041.3 mm3 , respectively, difference = 1625 mm3 , *P = 0.0003, n = 7 per group). Compared with the vector control group, N2a cells with forced HAS3 overexpression showed significantly increased neuron length (*P = 0.00082) and neurite outgrowth (*P = 0.00059). Intracellular changes in autophagy, including distorted mitochondria with abnormal circular inner membranes, were detected by transmission electron microscopy (TEM). Our study demonstrated that HAS3-mediated signaling activated by physiological concentrations of melatonin (>0.1 nmol/L) triggered significant N2a cell differentiation. These results provide molecular data with potential clinical relevance for therapeutic drug development.

SUBMITTER: Lee WJ 

PROVIDER: S-EPMC6712479 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Melatonin promotes neuroblastoma cell differentiation by activating hyaluronan synthase 3-induced mitophagy.

Lee Wen-Jui WJ   Chen Li-Ching LC   Lin Juo-Han JH   Cheng Tzu-Chun TC   Kuo Ching-Chuan CC   Wu Chih-Hsiung CH   Chang Hui-Wen HW   Tu Shih-Hsin SH   Ho Yuan-Soon YS  

Cancer medicine 20190705 10


Neuroblastoma is the second most common pediatric malignancy and has a high rate of spontaneous remission. Uncovering the mechanisms underlying neuroblastoma cell differentiation is critical for therapeutic purposes. A neuroblastoma cell line (N2a) treated with either serum withdrawal (<2.5%) or melatonin (>0.1 nmol/L) for 24 hours was used as a cell differentiation research model. Interestingly, the hyaluronan synthase 3 (HAS3) protein was induced in differentiated N2a cells. N2a-allografted nu  ...[more]

Similar Datasets

| S-EPMC8616223 | biostudies-literature
| S-EPMC6023397 | biostudies-literature
| S-EPMC8291816 | biostudies-literature
| S-EPMC4573567 | biostudies-literature
| S-EPMC3931655 | biostudies-literature
| S-EPMC8643260 | biostudies-literature
| S-EPMC6687147 | biostudies-literature
| S-EPMC3234988 | biostudies-literature
| S-EPMC2718450 | biostudies-literature
| S-EPMC3778714 | biostudies-literature